InvestLog
IMVT logo

IMVT

Immunovant, Inc.NASDAQHealthcare
$24.50-2.39%ClosedMarket Cap: $4.99B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-10HC Wainwright & Co.—Buy—
2026-02-09Guggenheim—Buy—
2026-01-08Truist Securities—Hold—
2026-01-06Wolfe Research—Outperform—
2025-12-15Goldman Sachs—Neutral—
2025-09-30JP Morgan—Overweight—
2025-09-04HC Wainwright & Co.—Buy—
2025-08-12JP Morgan—Overweight—
2025-08-12B of A Securities—Buy—
2025-07-28UBS—Neutral—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Wed Mar 31$-2.57$6.6M10
Fri Mar 31$-2.46$107.5M13
Sat Mar 31$-1.37$460.4M8
Sun Mar 31$2.09$1.25B3